In pancreatic cancer, for instance, the ablation of FAP+ CAFs has paradoxically led to accelerated tumor progression and increased Treg cell infiltration, raising concerns about the safety and effectiveness of directly targeting FAP and α‐SMA [435, 436]. This evidence concerns the gene ACTA1 and familial pancreatic carcinoma.